 |
|
Feminizing Adrenocortical Carcinoma With Cushing's Syndrome and Pseudohyperparathyroidism
Diosdado N. deAsis, Jr, MD;
Naguib A. Samaan, MD, PhD
Arch Intern Med. 1978;138(2):301-303.
Abstract
A patient with adrenocortical carcinoma had three major endocrine abnormalities attributable directly to the tumor: hypercortisolism (Cushing's syndrome), hyperestrogenism (feminization), and hypercalcemia (pseudohyperparathyroidism). There were higher levels of immunoreactive parathyroid hormone in venous effluent from the tumor or its abdominal metastases compared to that found in the veins draining the parathyroid glands. This, together with the presence of normal parathyroid glands on autopsy, established the diagnosis of pseudohyperparathyroidism as the cause of hypercalcemia in this patient.
(Arch Intern Med 138:301-303, 1978)
Author Affiliations
From the Section of Endocrinology, Department of Medicine, University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston.
Footnotes
Accepted for publication June 8, 1977.
Reprint requests to Section of Endocrinology, Department of Medicine, M. D. Anderson Hospital and Tumor Institute, 6723 Bertner Ave, Houston, TX 77030 (Dr Samaan).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Differential Expression of Parathyroid Hormone-Related Protein in Adrenocortical Tumors: Autocrine/Paracrine Effects on the Growth and Signaling Pathways in H295R Cells
Rizk-Rabin et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2275-2285.
ABSTRACT
| FULL TEXT
PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells
Mazzocchi et al.
Am. J. Physiol. Endocrinol. Metab. 2001;280:E209-E213.
ABSTRACT
| FULL TEXT
|
